Home
  • Rankings
  • Fortune 500 India
    Most Powerful Women
    The Next 500
    Forty Under Forty
    Best B-Schools
    MNC 500
  • Profiles
  • Companies
    People
  • Business
  • Markets
  • Cryptocurrency
    IPO
    Stock Market
  • Economy
  • Personal Finance
  • Tax
    Mutual Funds
    Banking
  • Opinion
    Technology
    Auto
    Lifestyle
    Long Reads
    First Edit
    Ideas
    Buy on Amazon
    Magazine Annual Subscription
  • Archives
  • Enterprise
    Investing
    Macro
    Infographics
  • Home
    • News
      • Business
      • Markets
      • Economy
      • Personal Finance
      • Opinion
      • Technology
      • Auto
      • Lifestyle
    • Media
      • Videos
      • Short Videos
      • Visual Stories
    • Magazine
      • July 2025
      • June 2025
      • May 2025
      • April 2025
      • March 2025
      • February 2025
      • January 2025
    • Rankings
      • Fortune 500 India
      • Most Powerful Women
      • The Next 500
      • Forty Under Forty
      • Best B-Schools
      • MNC 500
    • Profiles
      • Companies
      • People
Just In
Priya Nair to succeed Rohit Jawa as the MD and CEO of HUL, effective 1st August.
TCS records a Total Contract Value (TCV) of $9.4 billion in Q1 FY26.
“We saw robust deal closures during this quarter. We remain closely connected to our customers to help them navigate the challenges impacting their business through, among others, AI-led transformation,” K Krithivasan, CEO and MD, TCS.
“The continued global macroeconomic and geopolitical uncertainties caused a demand contraction (in the quarter),” K Krithivasan, CEO and MD, TCS.
Priya Nair to succeed Rohit Jawa as the MD and CEO of HUL, effective 1st August.
TCS records a Total Contract Value (TCV) of $9.4 billion in Q1 FY26.
“We saw robust deal closures during this quarter. We remain closely connected to our customers to help them navigate the challenges impacting their business through, among others, AI-led transformation,” K Krithivasan, CEO and MD, TCS.
“The continued global macroeconomic and geopolitical uncertainties caused a demand contraction (in the quarter),” K Krithivasan, CEO and MD, TCS.

Biotech

(7 search results)

The visionary biotech entrepreneur: Arun Asaithambi’s journey from PhD to NASDAQ

The visionary biotech entrepreneur: Arun Asaithambi’s journey from PhD to NASDAQ

Apr 9, 2024 4:33pm IST
Innovation-led Indian healthcare market to hit $320 bn by FY28: Bain

Innovation-led Indian healthcare market to hit $320 bn by FY28: Bain

Mar 6, 2024 7:01pm IST
Roche launches 2-in-1 biotech drug for breast cancer in India

Roche launches 2-in-1 biotech drug for breast cancer in India

May 13, 2022 10:05am IST
Covid-19 put spotlight on vaccines, diagnostics: Mazumdar-Shaw

Covid-19 put spotlight on vaccines, diagnostics: Mazumdar-Shaw

Feb 3, 2022 12:46pm IST
The Ellas of Bharat Biotech: The gift of the jab

The Ellas of Bharat Biotech: The gift of the jab

May 7, 2021 3:25pm IST
August records lowest M&A, PE deal values in 2018: Grant Thornton

August records lowest M&A, PE deal values in 2018: Grant Thornton

Sep 12, 2018 6:18pm IST
Is Biocon undervalued?

Is Biocon undervalued?

Jul 25, 2017 3:42pm IST
HomeTopicBiotech
Follow us
Published by the RP-Sanjiv Goenka Group, Fortune India - the Indian edition of Fortune magazine - sets the benchmark for editorial excellence and thought leadership in Indian business journalism.
Rankings
  • Fortune 500 India
  • Most Powerful Women
  • The Next 500
  • Forty Under Forty
  • Best B-Schools
  • MNC 500
Profiles
  • Companies
  • People
Most Read Sections
  • Business
  • Markets
  • Economy
  • Personal Finance
  • Opinion
Media
  • Videos
  • Short Videos
  • Visual Stories
Magazines
  • June 2025
  • May 2025
  • April 2025
  • March 2025
  • February 2025
  • January 2025
  • Privacy & Cookie Policy
  • Terms of Use
  • Vision & Core Values
  • Contact Us
© 2025 Fortune India. All Rights Reserved.